Fewer transfusions are still more—red blood cell transfusions affect long-term mortality in cardiac surgery
European Journal of Cardio-Thoracic Surgery · 03.04.2023 · 63 (4)
DOI: 10.1093/ejcts/ezad101 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 21.03.2023. Verfasst von Mariann Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aarhus University Hospital, Denmark. Hauptthemen laut MEDLINE: Erythrocyte Transfusion, Cardiac Surgical Procedures. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES Previous studies indicated higher long-term mortality after the transfusion of allogeneic red blood cells (RBC); newer recommendations emphasize lower transfusion rates. The consequences of the transfusion of RBCs in cardiac surgery are unclear because later studies focused on transfusion triggers and short-term outcomes. Reports on long-term complications after cardiac surgery are few. MATERIAL AND METHODS The mandatory Western Denmark Heart Registry was used to identify all adult cardiac operations performed in 4 centres from 2000 to 2019. Patients with multiple entries or previous cardiac operations, special/complex procedures, dying within 30 days and not eligible for follow-up were excluded. RESULTS A total of 32,581 adult cardiac operations performed in 4 centres from 2000 to 2019 were included. The Kaplan–Meier survival plot for low-risk patients undergoing simple cardiac operations showed a significantly lower 15-year survival (0.384 vs 0.661) of patients who received perioperative RBC transfusions [odds ratio 2.43 (confidence level 2.23–2.66)]. The risk decreased with increasing comorbidity or age. No difference was found in high-risk patients. The adjusted risk ratio after an RBC transfusion, including age, sex, comorbidity and surgery, was 1.62 (1.48–1.77). CONCLUSIONS Despite reduced transfusion rates, long-term follow-up on especially low-risk patients undergoing comparable cardiac operations still demonstrates substantially more deaths of patients receiving perioperative RBC transfusions. Even transfusion of 1–2 units is associated with increased long-term mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aarhus University Hospital, Denmark.
- Odense University Hospital, Denmark.
- Aalborg University Hospital, Denmark.
ORCID-Profile: Mariann Tang, Sisse Thomassen, Carl-Johan Jakobsen
Zitieren
APA
Tang, M., Ravn, H. B., Andreasen, J. J., Greisen, J., Thomassen, S., Fabrin, A., & Jakobsen, C. J. (2023). Fewer transfusions are still more—red blood cell transfusions affect long-term mortality in cardiac surgery. European Journal of Cardio-Thoracic Surgery, 63(4). https://doi.org/10.1093/ejcts/ezad101
Vancouver
Tang M, Ravn HB, Andreasen JJ, Greisen J, Thomassen S, Fabrin A, et al. Fewer transfusions are still more—red blood cell transfusions affect long-term mortality in cardiac surgery. European Journal of Cardio-Thoracic Surgery. 2023;63(4). doi:10.1093/ejcts/ezad101
BibTeX
@article{Tang2023,
author = {Tang, Mariann and Ravn, Hanne Berg and Andreasen, Jan Jesper and Greisen, Jacob and Thomassen, Sisse and Fabrin, Anja and Jakobsen, Carl-Johan},
title = {Fewer transfusions are still more—red blood cell transfusions affect long-term mortality in cardiac surgery},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2023},
volume = {63},
number = {4},
doi = {10.1093/ejcts/ezad101}
}
EUVIMED